• Home
  • About Us
  • Cancer Supportive Care
  • Pipeline
  • Business Development
  • News & Events
  • Contact
  • Company Overview
  • Strategy
  • Management
  • Board of Directors
  • Clinical Advisers
  • Investors
  • Overview
  • Post-Operative Nausea & Vomiting
  • Chemotherapy Induced Nausea & Vomiting
  • Xerostomia
  • Cancer Cachexia
  • Useful Links
  • Overview
  • APD421
  • APD403
  • APD515
  • APD209
  • News
  • Events
  • Downloads
Acacia Pharma

Cancer Supportive Care

Enabling better cancer treatment, ensuring better quality of life.

News > Downloads

13th December 2011APD209 Phase IIa Clinical Data - 6th Cachexia Conference Milan, December 9th 2011.pdf
4th November 2011BioEurope 2011 Presentation, November 2nd 2011.pdf

Latest News

4th January 2012
Acacia Pharma Initiates Phase II Study With APD421 In Post-Operative Nausea & Vomiting (PONV)

6th December 2011
Acacia Pharma Announces Positive Results From Phase IIa Cancer Cachexia Study

25th July 2011
Acacia Pharma Starts Phase II Clinical Trial With APD515 For Xerostomia
Acacia Pharma Ltd, Harston Mill, Harston, Cambridge, CB22 7GG
Tel: +44 (0)1223 875130 Fax: +44 (0)1223 875131
Website by College Hill Life Sciences